Lesion heterogeneity in multiple sclerosis: a study of the relations between appearances on T1 weighted images, T1 relaxation times, and metabolite concentrations
about
Biomarkers in Multiple Sclerosis: An Up-to-Date OverviewDiffusivity in multiple sclerosis lesions: At the cutting edge?Biomarkers and surrogate outcomes in neurodegenerative disease: lessons from multiple sclerosis.Imaging of multiple sclerosis: role in neurotherapeutics.Changes and variability of proton density and T1 relaxation times in early multiple sclerosis: MRI markers of neuronal damage in the cerebral cortex.Multimodal quantitative MRI assessment of cortical damage in relapsing-remitting multiple sclerosis.The Relationship between Gray Matter Quantitative MRI and Disability in Secondary Progressive Multiple SclerosisLongitudinal quantitative MRI assessment of cortical damage in multiple sclerosis: A pilot study.Increased diffusivity in acute multiple sclerosis lesions predicts risk of black holeThe effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis.Quantitation of normal metabolite concentrations in six brain regions by in-vivoH-MR spectroscopy.The emerging role of MRI in multiple sclerosis and the new diagnostic criteria.Diffusely abnormal white matter in progressive multiple sclerosis: in vivo quantitative MR imaging characterization and comparison between disease types.Perfusion and Diffusion Abnormalities of Multiple Sclerosis Lesions and Relevance of Classified Lesions to Disease Status.Mechanisms of normal appearing corpus callosum injury related to pericallosal T1 lesions in multiple sclerosis using directional diffusion tensor and 1H MRS imaging.Brain Metabolite Changes in Patients with Relapsing-Remitting and Secondary Progressive Multiple Sclerosis: A Two-Year Follow-Up StudyMultisequence-imaging protocols to detect cortical lesions of patients with multiple sclerosis: observations from a post-mortem 3 Tesla imaging studyNeuroradiological evaluation of demyelinating diseaseNew imaging techniques in the diagnosis of multiple sclerosis.Measuring Brain Tissue Integrity during 4 Years Using Diffusion Tensor Imaging.Neuropathologic correlates of magnetic resonance imaging in multiple sclerosis.Insight into Metabolic 1H-MRS Changes in Natalizumab Induced Progressive Multifocal Leukoencephalopathy Brain Lesions.Multicontrast MRI Quantification of Focal Inflammation and Degeneration in Multiple Sclerosis.Resolving relaxometry and diffusion properties within the same voxel in the presence of crossing fibres by combining inversion recovery and diffusion-weighted acquisitions.Serial proton spectroscopy, magnetization transfer ratio and T 2 relaxation in pseudotumoral demyelinating lesions.Proton MR spectroscopy of lesion evolution in multiple sclerosis: Steady-state metabolism and its relationship to conventional imaging.Normal-appearing grey and white matter T1 abnormality in early relapsing-remitting multiple sclerosis: a longitudinal study.Translocator positron-emission tomography and magnetic resonance spectroscopic imaging of brain glial cell activation in multiple sclerosis.Silent cerebral infarct definitions and full-scale IQ loss in children with sickle cell anemia.
P2860
Q27496017-03AB0872-7D89-47C0-A9C3-6F6DEA53C52CQ29301403-D055D230-4578-4125-83B3-7EEF8033D94EQ30983016-146821A5-8DF6-439F-9E1C-C85568A5DF8AQ30989935-279D5321-2C59-4AD0-8241-ECB6CD772259Q31009955-1934264A-169B-46BA-9770-392973D4725EQ31092111-7DDFA065-6270-4381-8AF1-C5D9FCB5AA5BQ31121073-435024C4-E144-4D6D-A6EC-BECED33BD213Q31166761-8DBDE465-39D3-423B-B49A-A15EF7928D5DQ33586037-F9F4D687-A1D7-4899-A745-A0A69D3BFA5EQ33698702-CEF8660F-33C7-44BD-993F-EF0A7D847EDDQ33711896-0D0C343F-08AB-4160-BCA9-AD06E3FADC8FQ34590306-F7FA85B9-BFE2-4772-8947-977B1C140665Q35009150-091E2CB8-8305-4433-812A-5F28A764F2E0Q35021647-173D7B79-362C-4A6F-A28F-DAD83D470A58Q35483352-4BA7D134-621B-4217-B652-D91B098F65D3Q36135627-14C7A05F-22AF-4434-8694-24380D3B1CC0Q36418075-F396EEE4-6AAC-42D5-840E-AF352B72DE7EQ36999734-4A598DC0-673B-46B7-B169-E357A1DA8024Q37428790-B6CDDBB7-4055-4241-8B31-7E9E4383785EQ37583874-4047F0CC-45D0-4E4D-9C26-521D4081934BQ38034611-C00FBD72-C75C-4E91-BE8F-6770A1C42CD5Q41455235-4A709117-2604-478F-80A4-CF30450E17CAQ42433959-AD186B98-2138-438E-A79E-DAA17D43213CQ42544794-178E028F-EAEA-438F-9D09-D0912C5A719FQ44060591-F6111FD4-47BD-4547-B9D8-DAA114E86DD4Q48122818-B843D146-E00A-428F-A74A-8C6D3209500EQ48199612-CBE7FFB5-76C8-4D44-BF64-F8A76AF554BCQ48411197-27E674B8-C3E7-4DA2-879A-355F9AC889ABQ52739085-D5BC8351-E013-443B-8B13-627EC5B92B90
P2860
Lesion heterogeneity in multiple sclerosis: a study of the relations between appearances on T1 weighted images, T1 relaxation times, and metabolite concentrations
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Lesion heterogeneity in multip ...... and metabolite concentrations
@ast
Lesion heterogeneity in multip ...... and metabolite concentrations
@en
type
label
Lesion heterogeneity in multip ...... and metabolite concentrations
@ast
Lesion heterogeneity in multip ...... and metabolite concentrations
@en
prefLabel
Lesion heterogeneity in multip ...... and metabolite concentrations
@ast
Lesion heterogeneity in multip ...... and metabolite concentrations
@en
P2093
P2860
P356
P1476
Lesion heterogeneity in multip ...... and metabolite concentrations
@en
P2093
A J Thompson
D H Miller
G J Barker
G J Parker
P D Molyneux
P2860
P304
P356
10.1136/JNNP.68.5.627
P407
P577
2000-05-01T00:00:00Z